Emil J. Freireich

33.6k total citations · 7 hit papers
497 papers, 25.6k citations indexed

About

Emil J. Freireich is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Emil J. Freireich has authored 497 papers receiving a total of 25.6k indexed citations (citations by other indexed papers that have themselves been cited), including 239 papers in Hematology, 137 papers in Oncology and 126 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Emil J. Freireich's work include Acute Myeloid Leukemia Research (173 papers), Acute Lymphoblastic Leukemia research (114 papers) and Chronic Lymphocytic Leukemia Research (85 papers). Emil J. Freireich is often cited by papers focused on Acute Myeloid Leukemia Research (173 papers), Acute Lymphoblastic Leukemia research (114 papers) and Chronic Lymphocytic Leukemia Research (85 papers). Emil J. Freireich collaborates with scholars based in United States, United Kingdom and Malaysia. Emil J. Freireich's co-authors include Michael J. Keating, Hagop M. Kantarjian, Gerald P. Bodey, Kenneth B. McCredie, Elihu H. Estey, Emil Frei, Jörge E. Cortes, E. A. Gehan, Susan O’Brien and David P. Rall and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Emil J. Freireich

493 papers receiving 23.4k citations

Hit Papers

Quantitative comparison o... 1962 2026 1983 2004 1966 1983 1982 2000 2000 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emil J. Freireich United States 81 10.9k 7.3k 6.6k 6.0k 5.0k 497 25.6k
Jack W. Singer United States 85 15.8k 1.4× 7.3k 1.0× 4.5k 0.7× 5.4k 0.9× 2.8k 0.5× 472 26.0k
Gerhard Ehninger Germany 78 13.6k 1.2× 6.5k 0.9× 5.2k 0.8× 6.1k 1.0× 3.8k 0.8× 678 25.0k
Hillard M. Lazarus United States 76 13.4k 1.2× 7.0k 1.0× 5.9k 0.9× 4.6k 0.8× 5.6k 1.1× 545 25.8k
Peter H. Wiernik United States 69 6.4k 0.6× 7.1k 1.0× 2.6k 0.4× 5.2k 0.9× 3.4k 0.7× 511 19.7k
John M. Goldman United Kingdom 83 22.2k 2.0× 5.1k 0.7× 14.3k 2.2× 5.1k 0.9× 3.3k 0.7× 496 29.8k
Michele Baccarani Italy 80 20.3k 1.9× 5.9k 0.8× 14.6k 2.2× 4.9k 0.8× 3.4k 0.7× 711 29.1k
Dietger Niederwieser Germany 73 18.3k 1.7× 5.4k 0.7× 7.5k 1.2× 4.4k 0.7× 4.5k 0.9× 535 26.8k
Bob Löwenberg Netherlands 89 23.5k 2.2× 8.0k 1.1× 5.9k 0.9× 14.3k 2.4× 6.5k 1.3× 534 35.9k
Barry E. Storer United States 85 16.5k 1.5× 8.4k 1.2× 3.5k 0.5× 2.4k 0.4× 5.3k 1.1× 429 28.2k
Miguel Á. Sanz Spain 58 17.4k 1.6× 3.4k 0.5× 4.3k 0.7× 8.5k 1.4× 4.3k 0.9× 486 22.5k

Countries citing papers authored by Emil J. Freireich

Since Specialization
Citations

This map shows the geographic impact of Emil J. Freireich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil J. Freireich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil J. Freireich more than expected).

Fields of papers citing papers by Emil J. Freireich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emil J. Freireich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil J. Freireich. The network helps show where Emil J. Freireich may publish in the future.

Co-authorship network of co-authors of Emil J. Freireich

This figure shows the co-authorship network connecting the top 25 collaborators of Emil J. Freireich. A scholar is included among the top collaborators of Emil J. Freireich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emil J. Freireich. Emil J. Freireich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kantarjian, Hagop M., Courtney D. DiNardo, Graciela M. Nogueras‐González, et al.. (2018). Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000. Cancer. 124(12). 2534–2540. 20 indexed citations
2.
Borthakur, Gautam, Michael G. Rosenblum, Moshe Talpaz, et al.. (2012). Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies. Haematologica. 98(2). 217–221. 60 indexed citations
3.
Freireich, Emil J. & Hagop Kantarjian. (1998). Medical management of hematological malignant diseases. Marcel Dekker eBooks. 2 indexed citations
4.
Freireich, Emil J. & Sanford A. Stass. (1995). Molecular basis of oncology. 13 indexed citations
5.
Freireich, Emil J. & Hagop M. Kantarjian. (1991). Therapy of hematopoietic neoplasia. M. Dekker eBooks. 9 indexed citations
6.
Kurzrock, Razelle, Hagop M. Kantarjian, CA Koller, et al.. (1991). 2-Chlorodeoxyadenosine: A new anticancer agent in lymphoid malignancies. 43(3). 253–258. 3 indexed citations
7.
Kurzrock, Razelle, Moshe Talpaz, Elihu H. Estey, et al.. (1991). Differential dose‐related haematological effects of GM‐CSF in pancytopenia: evidence supporting the advantage of low‐ over high‐dose administration in selected patients. British Journal of Haematology. 78(3). 352–358. 28 indexed citations
8.
Lotzová, Eva, C. A. Savary, Klára Tótpál, et al.. (1991). Highly oncolytic adherent lymphocytes: Therapeutic relevance for leukemia. Leukemia Research. 15(4). 245–254. 14 indexed citations
9.
Blumenschein, G. R., H. Y. Yap, Robert S. Benjamin, & Emil J. Freireich. (1982). Clinical sequence relationship between vinblastine and doxorubicin. 8(6). 583–585. 1 indexed citations
10.
Keating, Michael J., K. B. McCredie, Gerald P. Bodey, & Emil J. Freireich. (1981). Short-term sequential (S-TS) chemotherapy in young patients with acute myelogenous leukemia (AML). Proceedings of the American Association for Cancer Research. 22. 2 indexed citations
11.
Bodey, Gerald P., et al.. (1979). Chemotherapy alone for management of stage I and II malignant lymphoma of unfavorable histology. Proceedings of the American Association for Cancer Research. 20. 1 indexed citations
12.
Cabanillas, Fernando, Gerald P. Bodey, M. A. Burgess, & Emil J. Freireich. (1979). Results of a phase II study of maytansine in patients with breast carcinoma and melanoma.. PubMed. 63(3). 507–9. 12 indexed citations
13.
Rodríguez, V., Gerald P. Bodey, & Emil J. Freireich. (1977). Increased remission rate and prolongation of survival in patients with soft tissue sarcomas treated with intensive chemotherapy on a protected environment prophylactic antibiotic program (PEPA). Proceedings of the American Association for Cancer Research. 18. 6 indexed citations
14.
Lewinski, U, Giora M. Mavligit, E. M. Hersh, & Emil J. Freireich. (1977). Levamisole induced decline in lymphocyte content of cAMP among patients with solid tumors. Proceedings of the American Association for Cancer Research. 18. 1 indexed citations
15.
Barlogie, Barthel, Benjamin Drewinko, Johannes Schumann, & Emil J. Freireich. (1976). Pulse cytophotometric analysis of cell cycle perturbation with bleomycin in vitro.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(3). 1182–7. 34 indexed citations
16.
Gutterman, Jordan U., George R. Blumenschein, Gabriel N. Hortobágyi, et al.. (1976). Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.. BMJ. 2(6046). 1222–1225. 61 indexed citations
17.
Minow, Robert A., Jeffrey A. Gottlieb, & Emil J. Freireich. (1975). Electrocardiogram QRS voltage changes in adriamycin cardiomyopathy. Proceedings of the American Association for Cancer Research. 16(66). 5 indexed citations
18.
Speer, John F., et al.. (1974). Identification of smouldering leukemia by delaying chemotherapy. Proceedings of the American Association for Cancer Research. 15. 2 indexed citations
19.
Karon, Myron, Emil J. Freireich, & Emil Frei. (1962). A PRELIMINARY REPORT ON VINCRISTINE SULFATE—A NEW ACTIVE AGENT FOR THE TREATMENT OF ACUTE LEUKEMIA. PEDIATRICS. 30(5). 791–796. 47 indexed citations
20.
Shnider, Bruce I., Emil Frei, John G. Gorman, et al.. (1960). Clinical Studies of 6-Azauracil. Cancer Research. 20(1). 28–33. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026